advanced solid tumor
Showing NaN - NaN of 54
Advanced Solid Tumor Trial in Beijing (BB3008 tablet)
Recruiting
- Advanced Solid Tumor
- BB3008 tablet
-
Beijing, Beijing, China
- +1 more
Nov 19, 2023
Advanced Solid Tumor Trial in Beijing (Simmitinib, SG001)
Not yet recruiting
- Advanced Solid Tumor
-
Beijing, Beijing, ChinaCancer Hospital,Chinese Academy of Medical Sciences and Peking U
Nov 9, 2023
Advanced Solid Tumor Trial in Beijing (LK101 injection)
Recruiting
- Advanced Solid Tumor
- LK101 injection
-
Beijing, Beijing, China
- +1 more
Sep 22, 2023
Advanced Solid Tumor Trial in Beijing (SY-3505)
Recruiting
- Advanced Solid Tumor
-
Beijing, ChinaCancer Hospital, Chinese Academy of Medical Sciences
Sep 15, 2023
Advanced Solid Tumor Trial in Beijing (QLF3108)
Recruiting
- Advanced Solid Tumor
-
Beijing, Beijing, ChinaChinese People's Liberation Army (PLA) General Hospital
Aug 29, 2023
Advanced Solid Tumor Trial in Beijing (CD73 Antigen)
Recruiting
- Advanced Solid Tumor
- CD73 Antigen
-
Beijing, ChinaBeijing Cancer Hospital
Jul 10, 2023
Advanced Solid Tumor Trial in Beijing (aPD1-MSLN-CAR T Cells)
Not yet recruiting
- Advanced Solid Tumor
- αPD1-MSLN-CAR T Cells
-
Beijing, ChinaNational Cancer Center Cancer Hospital Chinese Academy of Medica
Jul 13, 2023
Advanced Solid Tumor Trial in Beijing (YK0901 cells)
Not yet recruiting
- Advanced Solid Tumor
- YK0901 cells
-
Beijing, ChinaDepartment of GI Oncology, Peking University Cancer Hospital
Jun 27, 2023
Advanced Solid Tumor Trial in Beijing (BA1202)
Not yet recruiting
- Advanced Solid Tumor
-
Beijing, ChinaCancer Hospital, Chinese Academy of Medical Sciences
Jun 18, 2023
Advanced Solid Tumor Trial in Beijing (QLS12004)
Not yet recruiting
- Advanced Solid Tumor
-
Beijing, Beijing, ChinaThe Fifth Medical Center of the General Hospital of the Chinese
Apr 13, 2023
Advanced Solid Tumor Trial in Beijing (Inosine 0.2g orally 3 times/day, PD-1/PD-L1 inhibitor ,chemo/targeting)
Completed
- Advanced Solid Tumor
- Inosine 0.2g orally 3 times/day
- PD-1/PD-L1 inhibitor ,chemotherapy/targeting
-
Beijing, Beijing, ChinaQin li
Mar 30, 2023
Advanced Solid Tumor Trial in Beijing (KM602)
Not yet recruiting
- Advanced Solid Tumor
- KM602
-
Beijing, Beijing, ChinaBeijing Cancer Hospital
Mar 9, 2023
Advanced Solid Tumor, Advanced Lymphoma Trial in Australia, United States (CS5001)
Recruiting
- Advanced Solid Tumor
- Advanced Lymphoma
-
East Setauket, New York
- +9 more
Jan 17, 2023
Tumor Infiltrating Lymphocytes, Safety, Advanced Solid Tumor Trial in Beijing (TIL therapy)
Recruiting
- Tumor Infiltrating Lymphocytes
- +5 more
- TIL therapy
-
Beijing, Beijing, ChinaChinese PLA General Hospital
Dec 19, 2022
HER2-overexpressed Advanced Solid Tumors After Progression of
Not yet recruiting
- HER2
- +3 more
- Disitamab Vedotin
-
Beijing, Beijing, ChinaBeijing Cancer Hospital
Dec 14, 2022
Advanced Solid Tumor, Sarcoma, HNSCC Trial in China (T3011)
Recruiting
- Advanced Solid Tumor
- +6 more
- T3011
-
Hefei, Anhui, China
- +18 more
Oct 30, 2022
Advanced Solid Tumor, Lung Cancer, Liver Cancer Trial in China (T3011)
Recruiting
- Advanced Solid Tumor
- +4 more
- T3011
-
Bengbu, Anhui, China
- +6 more
Oct 24, 2022
Advanced Solid Tumor Trial (SHR-A2009)
Recruiting
- Advanced Solid Tumor
-
Beijing, Beijing, ChinaChinese PLA General Hospital-Department of Medical Oncology
Oct 20, 2022
Advanced Solid Tumor Trial in China (PD-1 mAb injection, TJ004309 Injection)
Recruiting
- Advanced Solid Tumor
- PD-1 monoclonal antibody injection
- TJ004309 Injection
-
Hefei, Anhui, China
- +25 more
Aug 2, 2022
Advanced Solid Tumor Trial in Australia, China, Hong Kong (HBM4003)
Active, not recruiting
- Advanced Solid Tumor
-
Kogarah, New South Wales, Australia
- +16 more
Aug 2, 2022